The immune cell actively shapes the contact zone, not just passively touching.
For decades, science knew the immune system's killer T cells could destroy cancer with surgical precision — but could not truly witness the act. Now, researchers in Geneva and Lausanne have used a technique called cryo-expansion microscopy to freeze and expand human cells without distorting them, producing the first nanometer-scale, three-dimensional images of T cells attacking tumors in real human tissue. What emerges is not merely a clearer picture, but a new vocabulary for understanding why some immune responses succeed and others fail — a question that sits at the heart of modern cancer treatment.
- Cancer immunotherapy saves some patients and puzzles others, and the gap between those outcomes has long resisted explanation at the molecular level.
- Previous imaging methods forced researchers to choose between resolution and fidelity, always distorting the very structures they needed to understand.
- Cryo-expansion microscopy sidesteps this dilemma by flash-freezing cells and inflating them uniformly with hydrogel, preserving spatial relationships while making molecular detail visible.
- The images revealed that killer T cells form dome-shaped contact zones and deploy toxin packets of unexpected variety — some single-cored, some multiple — suggesting the immune system has more than one way to strike.
- Crucially, the technique was applied directly to human tumor tissue, capturing T cells operating inside real tumors rather than in the artificial calm of a laboratory dish.
- Researchers now hold a molecular portrait of a successful immune attack — a reference point that could guide the design of more effective immunotherapies.
Your immune system carries a precision weapon: the killer T cell. When it finds a cancer cell, it doesn't scatter toxins indiscriminately — it locks on, forms a tightly organized contact point, and delivers a lethal payload through a narrow channel while leaving neighboring healthy cells untouched. Scientists have long known this happens. What they couldn't do was watch it happen in detail.
The obstacle was technical. Imaging at the nanometer scale — where molecules actually do their work — required slicing, freezing, and staining cells in ways that inevitably warped their architecture. Every existing method forced a compromise: resolution or breadth, fine detail or natural shape. A team at the University of Geneva and the University Hospital Center of Lausanne found a way through. Their approach, cryo-expansion microscopy, flash-freezes cells so rapidly that water solidifies before ice crystals can form and shatter the cell's structure. The frozen sample is then soaked in an absorbent hydrogel that expands it uniformly — physically stretching the cell like a sponge, making its interior visible under a standard microscope while preserving the true spatial relationships between molecules.
What the researchers saw reshaped the picture. At the contact point between killer T cell and target, the membrane curves into a dome — a shape linked to how the cells adhere to each other and to the immune cell's internal scaffolding. The toxic granules that deliver the killing blow proved unexpectedly varied: some carried a single concentrated core, others multiple cores, hinting at different modes of deployment the immune system may use.
The deeper breakthrough came when the team applied the technique not to isolated cells in a dish, but to actual human tumor samples. For the first time, they could observe killer T cells infiltrating a tumor in their real clinical environment, at nanometer resolution — a meaningful distinction, since a T cell's behavior in a petri dish may differ substantially from its behavior inside the dense, complex terrain of living tissue.
The findings carry direct weight for immunotherapy, the branch of cancer medicine that enlists or engineers the immune system to fight tumors. Checkpoint inhibitors and CAR-T therapies have produced dramatic results in some patients and none in others, and the reasons remain poorly understood. These images — showing what a successful immune attack looks like at the molecular level, in real human disease — offer a new reference point for researchers trying to close that gap.
Your immune system has a precision weapon. When a killer T cell finds cancer, it doesn't spray toxins everywhere—it locks onto its target, forms an exquisitely organized contact point, and delivers a lethal dose through a narrow channel. The surrounding healthy cells stay untouched. For decades, scientists knew this happened. What they couldn't do was watch it.
The barrier was technical. To see what happens at the nanometer scale—the scale where molecules do their work—researchers had to slice cells open, freeze them, stain them, all processes that warp and distort the delicate structures they were trying to study. Existing microscopes forced an impossible choice: get high resolution or keep a wide view, preserve the cell's natural shape or see fine detail. You couldn't have all three.
A team at the University of Geneva and the University Hospital Center of Lausanne found a way around this. They used a technique called cryo-expansion microscopy, which works like this: freeze the cell almost instantaneously at extreme cold, so fast that water turns solid without forming ice crystals that would shatter the cell's architecture. Then, soak the frozen sample in an absorbent hydrogel and let it expand, physically stretching the cell like a sponge soaking up water. The expansion makes everything bigger and easier to see under a regular microscope, but because the expansion is uniform, the spatial relationships between molecules stay true. The cell's near-native structure survives intact.
What they saw changed the picture. At the point where the killer T cell touches its target, the membrane doesn't lie flat. It forms a dome-like structure, and that dome's shape appears tied to how the cells stick to each other and to the internal scaffolding of the immune cell itself. The researchers also got their first clear look at cytotoxic granules—the packets of poison that kill the target cell. These granules aren't uniform. Some contain a single core where the active molecules concentrate. Others have multiple cores. The variation suggests different ways the immune system might deploy its weapons.
But the real breakthrough came when the team moved beyond isolated cells in a dish. They took human tumor samples and applied the same technique directly to tissue. For the first time, they could watch killer T cells as they actually infiltrated a tumor, see their molecular machinery at nanometer resolution, and study the immune response in its real clinical context. This matters because a T cell attacking a cancer cell in a petri dish might behave differently than one fighting in the dense, complex environment of an actual tumor.
The implications ripple outward into immunotherapy, the field of cancer treatment that harnesses the immune system's own weapons. Doctors now use checkpoint inhibitors and CAR-T cell therapies to wake up or engineer killer T cells to attack tumors. But success is inconsistent. Some patients respond dramatically. Others don't. Understanding what makes an immune attack succeed—and what stops it—could help researchers design better treatments. These images, with their unprecedented detail of how killer T cells organize themselves and deploy their toxins, provide a new reference point. They show what a successful attack looks like at the molecular level, and they open a window into studying immune responses not in artificial conditions but in the messy, three-dimensional reality of human disease.
Notable Quotes
At the point of contact between the immune cell and its target, the membrane forms a kind of dome, whose structure appears linked to adhesion interactions and internal cell organization.— Florent Lemaître, postdoctoral researcher at UNIGE
Direct observation of T lymphocytes infiltrating tumors at nanometer scale allows us to study immune responses in their clinical context and better understand what determines their effectiveness.— Benita Wolf, Chief Resident at CHUV
The Hearth Conversation Another angle on the story
Why does it matter that we can see this now? We already knew T cells killed cancer cells.
We knew it happened, but not how. It's like knowing a surgeon operates on a brain versus watching the surgery. The details change everything—we can now see what structures matter, what varies, what might be the difference between a T cell that wins and one that fails.
What does the dome structure tell us?
That's still being figured out. But it suggests the immune cell is actively shaping the contact zone, not just passively touching the target. The dome's architecture seems linked to how tightly the cells stick and how the immune cell organizes itself internally. That's a clue about what makes the attack precise.
You mentioned the granules have different structures. Why would that be?
We don't know yet. It could mean the immune system has different strategies—different ways to deliver the poison depending on the threat. Or it could be that granules change as they age or get used. That's the kind of question this imaging makes it possible to ask.
How does studying real tumors change the picture?
A T cell in a dish is like a soldier on a training ground. In a tumor, there's chaos—other cells, chemical signals, physical barriers, competing immune cells. Seeing how T cells actually behave in that environment tells us what works in the real fight, not just in theory.
What's the next step?
Understanding why some immune attacks succeed and others fail. If we can map what a winning T cell looks like at the molecular level, we might be able to engineer better ones or figure out what's blocking the ones that aren't working.